StartupCraftersLynQX

Dr. Jane Smith

Acme Therapeutics

Dr. Jane Smith.

Tier 2

Acme Therapeutics · jane.smith@example.com

Browse projectsImprove profile+ Add publication
Agents working
Profiler·Re-indexed 2 new PubMed papers into your profile done
Matchmaker·You appeared in 3 new sponsor shortlists running
Negotiator·Drafted reply to Helix Bio invite — awaiting your editapprove
Profile health
78%+12
+12 since last month
Booked hours · this month
12+33%
9 last month
Earnings YTD
$84.5k+19%
vs $71.2k same period
Profile views · 30d
47
by verified sponsors
Match appearances · 30d
8
in sponsor shortlists
2 open invitations

Phase 2 oncology PI consultant

Helix Bio · 8 hrs / month, 6 months · $450–$600/hr

NCT04XXXXXXMatchmaker · 92%

received 2 days ago

Diligence advisor (CMC manufacturing)

Bridgewater Bio Capital · 20 hrs total, single engagement · $700–$900/hr

Matchmaker · 87%

received 5 days ago

Profiler asks

Were you first author on the 2024 Cell paper on PD-L1 trafficking?

ORCID lists the publication but author position is ambiguous. First-author status raises Tier-2 confidence.

Capabilities — Skills × Insights × Tools × Experience

Skills

Phase 2 oncology trial designCMC strategyGLP toxicologyRegulatory CMC submissions

Insights

Adaptive Phase 2 design under FDA scrutinyEndpoint selection in solid tumors

Tools

GraphPad PrismSASSpotfireSimCYP

Experience

  • Pfizer 2018–2022 (Sr. Director CMC)
  • Acme Therapeutics 2022–present (CSO)

Active engagements

Fractional CMC advisor · Helix Bio

12 / 16 hrs this month · last activity yesterday

active